Praetorian Bio
Praetorian Bio develops oral vaccines aimed at preventing gum disease and reducing associated systemic health risks.
$1M Pre Seed ·
Source: eleconomista.es
Funding history ↓Signals
X account@praetorianbio · created May 12, 2026 (6 months old) · 2 followers
Website registeredFeb 7, 2024 (2 years old)
Funding rounds
- Pre Seed · $1MSource: eleconomista.es
- X account created
- Website created
Founders and team
FL
Francisco Leon Co-founder, immunologistsource: praetorianbio.com
Investors
Companies like Praetorian Bio
PProclaim$15M Series B+ · Jul 2023
PPrimmune TherapeuticsSeries B+ · Jan 2026KKandou$225M Series A · Mar 2026
NNeurocarrus
RRheumaGenSeries A · Dec 2025
CConvergen$15M Seed · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/praetorian-bio (get a free API key).